Mürver

Bitki adı: Elder, flowers, fruit
Bilimsel adı: Sambucus nigra
Cins: Sambucus
Familya: Adoxaceae
Diğer adları: Elder

MÜRVER -Sambucus nigra L (Caprifoliaceae). 4-10 m yükseklikte, bileşik yapraklı ve süt beyazı çiçekli bir ağaç. Olgun meyveleri yenir ve dallanndan masura yapılır. Eş anl. Kara mürver, Melesir. Mmdar ağ., Mindiraç, Patlak, Patlangaç. Patlangıç, Patlangoz, Patlankuç, Patlavuç, Patlayak, Şişni, Yalangoz. Yalankoz. Sambucus ebu/us L-Ayı otu. Azı otu, Cüce mürver, Hekimana (İnebolu). Kımçınk. Livor (Rize), Mürver otu. Patpatik. Pellempüs (Dörtyol). Purtlak, Sultan otu, (Gaziköy-Tekirdağ), Şahmelek otu. Şahmelik (Karadeniz bölgesi),,Şahmelik otu, Telligelin (Gazi Antep), Yabanî mürver. Yer mürveri, Yivdim. Yivdin (Giresun, Ordu, Samsun). 1-2 m yükseklikte, çok yıllık ve otsu bir tür. Meyveleri boyar madde olarak kullanılır. Bk. Güzel avrat otu.[Türkçe Bitki Adları Sözlüğü, Turhan Baytop, 2007]


Sambucus nigra

Genel Bilgiler


Duke – Ethnobotany

Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb24: 385
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Takeda
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb24: 387
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Lewis
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Uphof
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb20: 24
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb20: 24
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Al-Rawi
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | FontQuer
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke

Bilimsel Araştırmalar

The heterogeneity of exosomal populations has hindered our understanding of their biogenesis, molecular composition, biodistribution and functions. By employing asymmetric flow field-flow fractionation (AF4), we identified two exosome subpopulations (large exosome vesicles, Exo-L, 90-120 nm; small exosome vesicles, Exo-S, 60-80 nm) and discovered an abundant population of non-membranous nanoparticles termed 'exomeres' (~35 nm). Exomere proteomic profiling revealed an enrichment in metabolic enzymes and hypoxia, microtubule and coagulation proteins as well as specific pathways, such as glycolysis and mTOR signalling. Exo-S and Exo-L contained proteins involved in endosomal function and secretion pathways, and mitotic spindle and IL-2/STAT5 signalling pathways, respectively. Exo-S, Exo-L and exomeres each had unique N-glycosylation, protein, lipid, DNA and RNA profiles and biophysical properties. These three nanoparticle subsets demonstrated diverse organ biodistribution patterns, suggesting distinct biological functions. This study demonstrates that AF4 can serve as an improved analytical tool for isolating extracellular vesicles and addressing the complexities of heterogeneous nanoparticle subpopulations.

Makaleyi görüntüle
Background Extracellular vesicles (EVs) play an essential role in the communication between cells and transport of diagnostically significant molecules. A wide diversity of approaches utilizing different biochemical properties of EVs and a lack of accepted protocols make data interpretation very challenging. Scope of review This review consolidates the data on the classical and state-of-the-art methods for isolation of EVs, including exosomes, highlighting the advantages and disadvantages of each method. Various characteristics of individual methods, including isolation efficiency, EV yield, properties of isolated EVs, and labor consumption are compared. Major conclusions A mixed population of vesicles is obtained in most studies of EVs for all used isolation methods. The properties of an analyzed sample should be taken into account when planning an experiment aimed at studying and using these vesicles. The problem of adequate EVs isolation methods still remains; it might not be possible to develop a universal EV isolation method but the available protocols can be used towards solving particular types of problems. General significance With the wide use of EVs for diagnosis and therapy of various diseases the evaluation of existing methods for EV isolation is one of the key problems in modern biology and medicine.

Makaleyi görüntüle
Simple and complex carbohydrates (glycans) have long been known to play major metabolic, structural and physical roles in biological systems. Targeted microbial binding to host glycans has also been studied for decades. But such biological roles can only explain some of the remarkable complexity and organismal diversity of glycans in nature. Reviewing the subject about two decades ago, one could find very few clear-cut instances of glycan-recognition-specific biological roles of glycans that were of intrinsic value to the organism expressing them. In striking contrast there is now a profusion of examples, such that this updated review cannot be comprehensive. Instead, a historical overview is presented, broad principles outlined and a few examples cited, representing diverse types of roles, mediated by various glycan classes, in different evolutionary lineages. What remains unchanged is the fact that while all theories regarding biological roles of glycans are supported by compelling evidence, exceptions to each can be found. In retrospect, this is not surprising. Complex and diverse glycans appear to be ubiquitous to all cells in nature, and essential to all life forms. Thus, >3 billion years of evolution consistently generated organisms that use these molecules for many key biological roles, even while sometimes coopting them for minor functions. In this respect, glycans are no different from other major macromolecular building blocks of life (nucleic acids, proteins and lipids), simply more rapidly evolving and complex. It is time for the diverse functional roles of glycans to be fully incorporated into the mainstream of biological sciences.

Makaleyi görüntüle
Background Sleep disturbance is associated with inflammatory disease risk and all-cause mortality. Here, we assess global evidence linking sleep disturbance, sleep duration, and inflammation in adult humans. Methods A systematic search of English language publications was performed, with inclusion of primary research articles that characterized sleep disturbance and/or sleep duration or performed experimental sleep deprivation and assessed inflammation by levels of circulating markers. Effect sizes (ES) and 95% confidence intervals (CI) were extracted and pooled using a random effect model. Results A total of 72 studies (n > 50,000) were analyzed with assessment of C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor α (TNFα). Sleep disturbance was associated with higher levels of CRP (ES .12; 95% CI = .05-.19) and IL-6 (ES .20; 95% CI = .08-.31). Shorter sleep duration, but not the extreme of short sleep, was associated with higher levels of CRP (ES .09; 95% CI = .01-.17) but not IL-6 (ES .03; 95% CI: -.09 to .14). The extreme of long sleep duration was associated with higher levels of CRP (ES .17; 95% CI = .01-.34) and IL-6 (ES .11; 95% CI = .02-20). Neither sleep disturbances nor sleep duration was associated with TNFα. Neither experimental sleep deprivation nor sleep restriction was associated with CRP, IL-6, or TNFα. Some heterogeneity among studies was found, but there was no evidence of publication bias. Conclusions Sleep disturbance and long sleep duration, but not short sleep duration, are associated with increases in markers of systemic inflammation.

Makaleyi görüntüle
The molecular basis for breast cancer metastasis to the brain is largely unknown. Brain relapse typically occurs years after the removal of a breast tumour, suggesting that disseminated cancer cells must acquire specialized functions to take over this organ. Here we show that breast cancer metastasis to the brain involves mediators of extravasation through non-fenestrated capillaries, complemented by specific enhancers of blood-brain barrier crossing and brain colonization. We isolated cells that preferentially infiltrate the brain from patients with advanced disease. Gene expression analysis of these cells and of clinical samples, coupled with functional analysis, identified the cyclooxygenase COX2 (also known as PTGS2), the epidermal growth factor receptor (EGFR) ligand HBEGF, and the alpha2,6-sialyltransferase ST6GALNAC5 as mediators of cancer cell passage through the blood-brain barrier. EGFR ligands and COX2 were previously linked to breast cancer infiltration of the lungs, but not the bones or liver, suggesting a sharing of these mediators in cerebral and pulmonary metastases. In contrast, ST6GALNAC5 specifically mediates brain metastasis. Normally restricted to the brain, the expression of ST6GALNAC5 in breast cancer cells enhances their adhesion to brain endothelial cells and their passage through the blood-brain barrier. This co-option of a brain sialyltransferase highlights the role of cell-surface glycosylation in organ-specific metastatic interactions.

Makaleyi görüntüle

Kaynaklar ve Görseller

« Sambucus ebulus Sambucus williamsii »